Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness

Jaden Brandt

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (66)

  1. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. 2023-01-01 · Expand citations
  2. Applying Lessons From Cannabis to the Psychedelic Highway 2022-06-17 · Expand citations
  3. Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy. 2022-05-14 · Expand citations
  4. Policy in focus: Is psilocybin the next cannabis? 2021-11-15 · Expand citations
  5. Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment 2021-04-29 · Expand citations
  6. Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin. 2020-07-02 · Expand citations
  7. Production Options for Psilocybin: Making of the Magic. 2019-01-18 · Expand citations
  8. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  9. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  10. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  11. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  12. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  13. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  14. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  15. OpenAlex W1973613743
  16. OpenAlex W2025257299
  17. OpenAlex W2045595721
  18. OpenAlex W2072522556
  19. OpenAlex W2103048557
  20. OpenAlex W2108846054
  21. OpenAlex W2114183716
  22. OpenAlex W2132011757
  23. OpenAlex W2140018908
  24. OpenAlex W2166952073
  25. OpenAlex W2234681180
  26. OpenAlex W2290816644
  27. OpenAlex W2316694232
  28. OpenAlex W2504773786
  29. OpenAlex W2610144880
  30. OpenAlex W2753625084
  31. OpenAlex W2757917284
  32. OpenAlex W2781488255
  33. OpenAlex W2792164490
  34. OpenAlex W2797803761
  35. OpenAlex W2802638831
  36. OpenAlex W2808301300
  37. OpenAlex W2895986834
  38. OpenAlex W2897760082
  39. OpenAlex W2899027265
  40. OpenAlex W2911226174
  41. OpenAlex W2923355729
  42. OpenAlex W2969818417
  43. OpenAlex W2969964941
  44. OpenAlex W2971496197
  45. OpenAlex W3008649055
  46. OpenAlex W3037462750
  47. OpenAlex W3105653790
  48. OpenAlex W3106850904
  49. OpenAlex W3112173414
  50. OpenAlex W3135595060
  51. OpenAlex W3137839889
  52. OpenAlex W3165796092
  53. OpenAlex W3187215861
  54. OpenAlex W3193605940
  55. OpenAlex W3199682754
  56. OpenAlex W3202565570
  57. OpenAlex W3211291416
  58. OpenAlex W4200571248
  59. OpenAlex W4206147469
  60. OpenAlex W4220914378
  61. OpenAlex W4220928043
  62. OpenAlex W4223998676
  63. OpenAlex W4225857844
  64. OpenAlex W4229029658
  65. OpenAlex W4229333009
  66. OpenAlex W4229336530

Cited by — these papers cite this paper (1)

  1. From regulation to practice: A scoping review of prescribers’ roles in psilocybin-assisted therapy 2026-10-01 · Expand citations